These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32392632)

  • 1. Immunoglobulin G1 Antibodies Against Phosphorylcholine Are Associated With Protection in Systemic Lupus Erythematosus and Atherosclerosis: Potential Underlying Mechanisms.
    Thiagarajan D; Fiskesund R; Frostegård A; Steen J; Rahman M; Vikström M; Lundström S; Frostegård J
    ACR Open Rheumatol; 2020 Jun; 2(6):344-356. PubMed ID: 32392632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms.
    Rahman M; Sing S; Golabkesh Z; Fiskesund R; Gustafsson T; Jogestrand T; Frostegård AG; Hafström I; Liu A; Frostegård J
    Clin Immunol; 2016 May; 166-167():27-37. PubMed ID: 27102765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM antibodies against phosphorylcholine promote polarization of T regulatory cells from patients with atherosclerotic plaques, systemic lupus erythematosus and healthy donors.
    Sun J; Lundström SL; Zhang B; Zubarev RA; Steuer J; Gillgren P; Rahman M; Ajeganova S; Liu A; Frostegård J
    Atherosclerosis; 2018 Jan; 268():36-48. PubMed ID: 29175653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus.
    Anania C; Gustafsson T; Hua X; Su J; Vikström M; de Faire U; Heimbürger M; Jogestrand T; Frostegård J
    Arthritis Res Ther; 2010; 12(6):R214. PubMed ID: 21092251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies Against Phosphorylcholine Among 60-Year-Olds: Clinical Role and Simulated Interactions.
    Samal SK; Panda PK; Vikström M; Leander K; de Faire U; Ahuja R; Frostegård J
    Front Cardiovasc Med; 2022; 9():809007. PubMed ID: 35479288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural antibodies against phosphorylcholine as potential protective factors in SLE.
    Su J; Hua X; Concha H; Svenungsson E; Cederholm A; Frostegård J
    Rheumatology (Oxford); 2008 Aug; 47(8):1144-50. PubMed ID: 18522961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between dietary and metabolic factors and IgM antibodies to phosphorylcholine and malondialdehyde in patients with systemic lupus erythematosus and population-based matched controls.
    Lourdudoss C; Ajeganova S; Frostegård J
    Clin Exp Rheumatol; 2018; 36(3):428-433. PubMed ID: 29745894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic lupus erythematosus and cardiovascular disease.
    Frostegård J
    J Intern Med; 2023 Jan; 293(1):48-62. PubMed ID: 35982610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgM anti-phosphorylcholine antibodies associate with senescent and IL-17+ T cells in SLE patients with a pro-inflammatory lipid profile.
    López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; Benavente L; Caminal-Montero L; Suárez A
    Rheumatology (Oxford); 2020 Feb; 59(2):407-417. PubMed ID: 31302689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low levels of antibodies against oxidized but not nonoxidized cardiolipin and phosphatidylserine are associated with atherosclerotic plaques in systemic lupus erythematosus.
    Su J; Frostegård AG; Hua X; Gustafsson T; Jogestrand T; Hafström I; Frostegård J
    J Rheumatol; 2013 Nov; 40(11):1856-64. PubMed ID: 24037548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of IgG1 isotype phosphorylcholine antibodies for the treatment of inflammatory cardiovascular diseases.
    de Vries MR; Ewing MM; de Jong RCM; MacArthur MR; Karper JC; Peters EAB; Nordzell M; Karabina SAP; Sexton D; Dahlbom I; Bergman A; Mitchell JR; Frostegård J; Kuiper J; Ninio E; Jukema JW; Pettersson K; Quax PHA
    J Intern Med; 2021 Jul; 290(1):141-156. PubMed ID: 33342002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
    Gustafsson JT; Herlitz Lindberg M; Gunnarsson I; Pettersson S; Elvin K; Öhrvik J; Larsson A; Jensen-Urstad K; Svenungsson E
    PLoS One; 2017; 12(4):e0174572. PubMed ID: 28414714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary micronutrient intake and atherosclerosis in systemic lupus erythematosus.
    Lourdudoss C; Elkan AC; Hafström I; Jogestrand T; Gustafsson T; van Vollenhoven R; Frostegård J
    Lupus; 2016 Dec; 25(14):1602-1609. PubMed ID: 27334936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different subclasses and isotypes of antibodies against phosphorylcholine in haemodialysis patients: association with mortality.
    Samal SK; Qureshi AR; Rahman M; Stenvinkel P; Frostegård J
    Clin Exp Immunol; 2020 Jul; 201(1):94-104. PubMed ID: 32297318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.
    Svenungsson E; Engelbertsen D; Wigren M; Gustafsson JT; Gunnarsson I; Elvin K; Jensen-Urstad K; Fredrikson GN; Nilsson J
    Clin Exp Immunol; 2015 Sep; 181(3):417-26. PubMed ID: 25959453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-apolipoprotein A-I antibodies and paraoxonase 1 activity in Systemic Lupus Erythematosus.
    Ahmed MM; Elserougy EM; Al-Gazzar II; Fikry IM; Habib DF; Younes KM; Salem NA
    EXCLI J; 2013; 12():719-32. PubMed ID: 26622215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against Phosphorylcholine-Implications for Chronic Inflammatory Diseases.
    Frostegård J
    Metabolites; 2023 Jun; 13(6):. PubMed ID: 37367878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype.
    Bhat NM; Lee LM; van Vollenhoven RF; Teng NN; Bieber MM
    J Rheumatol; 2002 Oct; 29(10):2114-21. PubMed ID: 12375320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural antibodies against phosphorylcholine in cardiovascular disease.
    de Faire U; Frostegård J
    Ann N Y Acad Sci; 2009 Sep; 1173():292-300. PubMed ID: 19758165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
    Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
    Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.